Penfluridol regulates p62 / Keap1 / Nrf2 signaling pathway to induce ferroptosis in osteosarcoma cells
Open Access
- 11 July 2024
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 177, 117094
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21‐mediated ubiquitination/degradation of STAT1 in a GTP binding‐dependent modalityCancer Communications, 2022
- Ferroptosis in cancer and cancer immunotherapyCancer Communications, 2022
- SIRT6 silencing overcomes resistance to sorafenib by promoting ferroptosis in gastric cancerBiochemical and Biophysical Research Communications, 2021
- Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK/FOXO3a/BIM-dependent mannerActa Pharmaceutica Sinica B, 2021
- KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcomaBiochemical and Biophysical Research Communications, 2021
- Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0/G1 arrest and apoptosisBiomedicine & Pharmacotherapy, 2020
- Cancer stem cells in osteosarcomaCancer Letters, 2017
- Identification of ACSL4 as a biomarker and contributor of ferroptosisBiochemical and Biophysical Research Communications, 2016
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015
- Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agentsActa Pharmaceutica Sinica B, 2015